Cargando…

Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya

BACKGROUND: Tumors commonly are infiltrated by leukocytes, or tumor infiltrating leukocytes (TILs). It remains unclear, however, if the density and type of individual TILs has a direct or simply correlative role in promoting poor prognosis in breast cancer patients. Breast cancer in Kenyan women is...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawe, Rispah T., Mining, Simeon K., Ofulla, Ayub V., Patel, Kirtika, Guyah, Bernard, Chumba, David, Prosperi, Jenifer R., Kerper, Maggie, Shi, Zonggao, Sandoval-Cooper, Mayra, Taylor, Katherine, Badve, Sunil, Stack, M. Sharon, Littlepage, Laurie E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543450/
https://www.ncbi.nlm.nih.gov/pubmed/28794686
http://dx.doi.org/10.1186/s41182-017-0059-4
_version_ 1783255152099065856
author Sawe, Rispah T.
Mining, Simeon K.
Ofulla, Ayub V.
Patel, Kirtika
Guyah, Bernard
Chumba, David
Prosperi, Jenifer R.
Kerper, Maggie
Shi, Zonggao
Sandoval-Cooper, Mayra
Taylor, Katherine
Badve, Sunil
Stack, M. Sharon
Littlepage, Laurie E.
author_facet Sawe, Rispah T.
Mining, Simeon K.
Ofulla, Ayub V.
Patel, Kirtika
Guyah, Bernard
Chumba, David
Prosperi, Jenifer R.
Kerper, Maggie
Shi, Zonggao
Sandoval-Cooper, Mayra
Taylor, Katherine
Badve, Sunil
Stack, M. Sharon
Littlepage, Laurie E.
author_sort Sawe, Rispah T.
collection PubMed
description BACKGROUND: Tumors commonly are infiltrated by leukocytes, or tumor infiltrating leukocytes (TILs). It remains unclear, however, if the density and type of individual TILs has a direct or simply correlative role in promoting poor prognosis in breast cancer patients. Breast cancer in Kenyan women is aggressive with presentation at a young age, with advanced grade (grade III), large tumor size (>2.0 cm), and poor prognosis. We previously observed that the tumors were predominantly estrogen receptor positive (ER+) but also included both a high percentage of triple negative tumors and also increased immune cell infiltration within the tumors. We used breast tumor tissues from each patient to make tissue microarrays that were then stained for leukocyte and myeloid markers including CD4, CD8, CD20, CD25, CD68, and CD163 using immunohistochemical techniques. The immune cell infiltration into the cancer tissue included increased numbers of macrophages (CD68+), helper T cells (CD4+), and CD25+ lymphocytes compared to benign tissue. RESULTS: This study characterized the grade, molecular subtypes, and proliferation index of these tumors and determined if TIL density was enriched across any of these factors. We analyzed 49 malignant patient tissue samples for this study. The patient population had a mean age of 51.9 years. The tumors analyzed were heterogeneous by grade: grade I (6%), grade II (47%), and grade III (39%). Most patients presented with large tumors (>2.0 cm) (69%). We classified the tumors into molecular subtypes based on clinical marker expression. Based on this analysis, the molecular subtype distribution was heterogeneous with luminal B (41%), basal/triple negative (TN) (37%), luminal A (14%) and HER2 (8%) breast cancer subtypes. While the basal/TN subtype had a much higher proliferative index (Ki-67+) than did the other molecular subtypes, we did not see a significant correlation between TIL density and either subtype or tumor grade. Therefore, TIL density is independent of molecular subtype and grade. CONCLUSION: This study identified a Kenyan patient cohort that develops large, high-grade tumors primarily of the luminal B and basal molecular subtypes. After analyzing the TILs within these tumors, we found that immune cell infiltration of these tumors correlated with increased proliferation but not grade or molecular subtype. Future research is required to determine if the aberrant recruitment of TILs to tumors contributes to cancer progression and response to cancer treatments.
format Online
Article
Text
id pubmed-5543450
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55434502017-08-09 Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya Sawe, Rispah T. Mining, Simeon K. Ofulla, Ayub V. Patel, Kirtika Guyah, Bernard Chumba, David Prosperi, Jenifer R. Kerper, Maggie Shi, Zonggao Sandoval-Cooper, Mayra Taylor, Katherine Badve, Sunil Stack, M. Sharon Littlepage, Laurie E. Trop Med Health Research BACKGROUND: Tumors commonly are infiltrated by leukocytes, or tumor infiltrating leukocytes (TILs). It remains unclear, however, if the density and type of individual TILs has a direct or simply correlative role in promoting poor prognosis in breast cancer patients. Breast cancer in Kenyan women is aggressive with presentation at a young age, with advanced grade (grade III), large tumor size (>2.0 cm), and poor prognosis. We previously observed that the tumors were predominantly estrogen receptor positive (ER+) but also included both a high percentage of triple negative tumors and also increased immune cell infiltration within the tumors. We used breast tumor tissues from each patient to make tissue microarrays that were then stained for leukocyte and myeloid markers including CD4, CD8, CD20, CD25, CD68, and CD163 using immunohistochemical techniques. The immune cell infiltration into the cancer tissue included increased numbers of macrophages (CD68+), helper T cells (CD4+), and CD25+ lymphocytes compared to benign tissue. RESULTS: This study characterized the grade, molecular subtypes, and proliferation index of these tumors and determined if TIL density was enriched across any of these factors. We analyzed 49 malignant patient tissue samples for this study. The patient population had a mean age of 51.9 years. The tumors analyzed were heterogeneous by grade: grade I (6%), grade II (47%), and grade III (39%). Most patients presented with large tumors (>2.0 cm) (69%). We classified the tumors into molecular subtypes based on clinical marker expression. Based on this analysis, the molecular subtype distribution was heterogeneous with luminal B (41%), basal/triple negative (TN) (37%), luminal A (14%) and HER2 (8%) breast cancer subtypes. While the basal/TN subtype had a much higher proliferative index (Ki-67+) than did the other molecular subtypes, we did not see a significant correlation between TIL density and either subtype or tumor grade. Therefore, TIL density is independent of molecular subtype and grade. CONCLUSION: This study identified a Kenyan patient cohort that develops large, high-grade tumors primarily of the luminal B and basal molecular subtypes. After analyzing the TILs within these tumors, we found that immune cell infiltration of these tumors correlated with increased proliferation but not grade or molecular subtype. Future research is required to determine if the aberrant recruitment of TILs to tumors contributes to cancer progression and response to cancer treatments. BioMed Central 2017-08-04 /pmc/articles/PMC5543450/ /pubmed/28794686 http://dx.doi.org/10.1186/s41182-017-0059-4 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sawe, Rispah T.
Mining, Simeon K.
Ofulla, Ayub V.
Patel, Kirtika
Guyah, Bernard
Chumba, David
Prosperi, Jenifer R.
Kerper, Maggie
Shi, Zonggao
Sandoval-Cooper, Mayra
Taylor, Katherine
Badve, Sunil
Stack, M. Sharon
Littlepage, Laurie E.
Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya
title Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya
title_full Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya
title_fullStr Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya
title_full_unstemmed Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya
title_short Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya
title_sort tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of western kenya
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543450/
https://www.ncbi.nlm.nih.gov/pubmed/28794686
http://dx.doi.org/10.1186/s41182-017-0059-4
work_keys_str_mv AT sawerispaht tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT miningsimeonk tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT ofullaayubv tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT patelkirtika tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT guyahbernard tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT chumbadavid tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT prosperijeniferr tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT kerpermaggie tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT shizonggao tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT sandovalcoopermayra tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT taylorkatherine tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT badvesunil tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT stackmsharon tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya
AT littlepagelauriee tumorinfiltratingleukocytedensityisindependentoftumorgradeandmolecularsubtypeinaggressivebreastcancerofwesternkenya